Vext Science, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Eric Offenberger
- Full Time Employees
- 173
- Sector
- Process industries
- Industry
- Agricultural commodities/Milling
- Address
- 4152 North 39th Avenue Vancouver AZ Canada 85019
- IPO Date
- May 13, 2019
- Website
- vextscience.com
- Similar Companies
- Business
- Vext Science, Inc. is a U.S.-based cannabis operator with vertically integrated operations encompassing cultivation, manufacturing, and retail dispensaries primarily in Arizona and Ohio. The company produces and sells a diverse range of cannabis products including THC concentrates, edibles, distillate cartridges, and hemp-based products under its key brands such as Vapen™, Pure Touch Botanicals, Vapen CBD, and Herbal Wellness. Its product portfolio is created using in-house cultivated high-quality flower and distributed through its dispensaries and partnerships in multiple states. In addition to product sales, Vext provides management, advisory, cultivation, and dispensary services to other entities in the cannabis industry through joint operation agreements and licensing arrangements. Founded in 2015 and headquartered in Vancouver, Canada, Vext Science owns and operates state-of-the-art cultivation facilities, fully equipped manufacturing units, and retail dispensaries, with a significant presence in Arizona and Ohio. Recent major corporate developments include the acquisition of the Strawberry Fields dispensary in Columbus, Ohio, completed in early 2024, and the subsequent expansion through the Ohio Expansion Transaction, adding dispensaries in Athens and Jeffersonville. The company is on track to reach Ohio's retail dispensary license cap of eight, aiming to capitalize on the growing adult-use cannabis market in that state, expected to reach $4 billion by 2028. This expansion has driven strong financial growth, reflected in increased revenue and operating cash flow in 2024–2025. Vext Science's latest operational strategies emphasize scaling its vertically integrated presence in Ohio through acquisitions and new dispensary openings, enhancing cash flow and operational leverage. The company continues to develop award-winning product lines and expand its retail footprint while maintaining robust cultivation and production capabilities. Its leadership team has a proven track record of profitable multi-state cannabis operations since 2016, positioning Vext for sustained growth in the evolving U.S. cannabis market. This comprehensive vertical integration and geographic expansion solidify Vext Science's position in the cannabis industry, targeting medical and adult-use markets across key U.S. states with significant growth potential. The company combines product manufacturing under proprietary brands with service offerings such as cultivation management and dispensary operations to enhance market reach and profitability. Overall, Vext Science operates in the cannabis agriculture, manufacturing, and retail segments with a focus on premium THC and CBD products, leveraging recent strategic acquisitions and license expansions to strengthen its market presence and financial performance in its core U.S. markets of Arizona and Ohio.
Company News
Vext Provides Update on Jackson, Ohio Dispensary
Vext Announces Reopening of Jackson, Ohio Dispensary and Restructuring of Ohio Seller Notes Ahead of December 2026 Maturity
Vext Provides Operational Update on Jackson, Ohio Dispensary
Vext Science Inc. (VEXTF) Q2 2026 Earnings Call Transcript
Vext Reports Q2 2026 Financial Results; Opens Sixth Ohio Dispensary, Completes Arizona Cultivation Wind-Down; Adjusted EBITDA Grows for Second Consecutive Quarter
Vext Announces Date for Q2 2026 Financial Results Release
Vext Opens Sixth Ohio Dispensary in Fairfield
Vext Science Inc. (VEXTF) Q1 2026 Earnings Call Transcript
Vext Reports Q1 2026 Financial Results; Adjusted EBITDA up 73% Sequentially to $3.6 Million as Ohio Platform Scales
Vext Engages Zuanic & Associates
Vext Announces Date for Q1 2026 Financial Results Release
Vext Science Inc. (VEXTF) Q4 2025 Earnings Call Transcript
Vext Reports Q4 and FY 2025; Fiscal 2025 Revenue up +43% to $51.4M, Operating Cash Flow up +256% to $11.7M as Ohio Retail Scales
Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release
Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion
Vext Advances Ohio Expansion with Seventh Retail Location
Vext Science (OTCMKTS:VEXTF) Stock Price Up 14.2% – What’s Next?
Vext Announces Voting Results of Annual General Meeting
CORRECTION FROM SOURCE: Vext Reports Q3 2025 Financial Results
Vext Science Inc. (VEXTF) Q3 2025 Earnings Call Transcript